1. Home
  2. NVAX vs RVLV Comparison

NVAX vs RVLV Comparison

Compare NVAX & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • RVLV
  • Stock Information
  • Founded
  • NVAX 1987
  • RVLV 2003
  • Country
  • NVAX United States
  • RVLV United States
  • Employees
  • NVAX N/A
  • RVLV N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RVLV Catalog/Specialty Distribution
  • Sector
  • NVAX Health Care
  • RVLV Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • RVLV Nasdaq
  • Market Cap
  • NVAX 1.3B
  • RVLV 1.4B
  • IPO Year
  • NVAX 1995
  • RVLV 2019
  • Fundamental
  • Price
  • NVAX $8.60
  • RVLV $23.88
  • Analyst Decision
  • NVAX Buy
  • RVLV Buy
  • Analyst Count
  • NVAX 7
  • RVLV 14
  • Target Price
  • NVAX $14.29
  • RVLV $26.79
  • AVG Volume (30 Days)
  • NVAX 6.9M
  • RVLV 1.0M
  • Earning Date
  • NVAX 11-11-2025
  • RVLV 11-04-2025
  • Dividend Yield
  • NVAX N/A
  • RVLV N/A
  • EPS Growth
  • NVAX N/A
  • RVLV 38.54
  • EPS
  • NVAX 2.54
  • RVLV 0.63
  • Revenue
  • NVAX $1,078,718,000.00
  • RVLV $1,182,554,000.00
  • Revenue This Year
  • NVAX $61.69
  • RVLV $9.12
  • Revenue Next Year
  • NVAX N/A
  • RVLV $6.65
  • P/E Ratio
  • NVAX $3.18
  • RVLV $37.80
  • Revenue Growth
  • NVAX 9.22
  • RVLV 10.68
  • 52 Week Low
  • NVAX $5.01
  • RVLV $16.80
  • 52 Week High
  • NVAX $15.22
  • RVLV $39.58
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 53.41
  • RVLV 59.28
  • Support Level
  • NVAX N/A
  • RVLV $22.31
  • Resistance Level
  • NVAX $8.31
  • RVLV $24.01
  • Average True Range (ATR)
  • NVAX 0.35
  • RVLV 0.92
  • MACD
  • NVAX -0.25
  • RVLV 0.06
  • Stochastic Oscillator
  • NVAX 99.19
  • RVLV 86.66

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

Share on Social Networks: